Loss of Heterozygosity and Microsatellite Instability in Hepatocellular Carcinoma in Taiwan

Overview

Journal Br J Cancer

Specialty Oncology

Date 1999 Jul 17

PMID 10408855

Citations 12

Authors

J C Sheu

Y W Lin

H C Chou

G T Huang

H S Lee

Y H Lin

S Y Huang

C H Chen

J T Wang

P H Lee

J T Lin

F J Lu

D S Chen

Affiliations

Soon will be listed here.

Abstract

Elucidation of the basic genetic changes of human hepatocellular carcinoma is important for the understanding and treatment of this cancer. We used microsatellite polymorphism markers to study 30 cases of hepatocellular carcinoma (34 tumours) on all human chromosomes. DNA from 34 pairs of hepatocellular carcinomas and corresponding non-tumour parts was prepared. Loss of heterozygosity (LOH) and microsatellite instability on 23 chromosomes were investigated by 231 sets of microsatellite markers. More than 20% LOH was shown for loci on 16q (47.1%), 13q (32.4%), 17p (32.4%), 5q (26.5%), 11p (23.5%) and 9p (20.6%). The commonly affected regions were mapped to 16q12.1, 16q12.2, 16q24, 13q12.1-32, 17p13, 5q32, 5q34, 5q3, 11p15, 11q23-24 and 9p21. Hepatitis B virus carriers had a significantly higher frequency of LOH on chromosomes 5q, 11p and 16q. Furthermore, larger tumour size tended to have higher frequency of LOH at D16S409 locus (16q12.1). Microsatellte instability was only found in 12 of 231 markers and the frequency is very low. These data suggest that the chromosomes 16q, 13q, 17p, 5q, 11p and 9p might participate in hepatocarcinogenesis. However, microsatellite instability might play little role in the development of this cancer in Taiwan.

Citing Articles

A machine learning-based SNP-set analysis approach for identifying disease-associated susceptibility loci.

Silva P, Gaudillo J, Vilela J, Roxas-Villanueva R, Tiangco B, Domingo M Sci Rep. 2022; 12(1):15817.

PMID: 36138111 PMC: 9499949. DOI: 10.1038/s41598-022-19708-1.

Molecular Noninvasive Diagnosis of Hepatocellular Carcinoma Using Microsatellite Instability.

Mamdouh S, Aboushousha T, Abdelraouf A, Hamdy H, Seleem M, Hassan H Asian Pac J Cancer Prev. 2021; 22(10):3337-3346.

PMID: 34711011 PMC: 8858233. DOI: 10.31557/APJCP.2021.22.10.3337.

BRIT1 dysfunction confers synergistic inhibition of hepatocellular carcinoma by targeting poly (ADP-ribose) polymerases and PI3K.

Liang Y, Yu L, Zhang D, Zhao X, Gao H, Slagle B Am J Cancer Res. 2020; 10(6):1900-1918.

PMID: 32642299 PMC: 7339272.

Mutations in and nucleotide excision repair genes are correlated with prognosis of hepatitis B virus-associated hepatocellular carcinoma.

Su W, Jou Y, Zhang J, Ho C, Tai D J Cancer. 2018; 9(15):2678-2686.

PMID: 30087708 PMC: 6072809. DOI: 10.7150/jca.25438.

Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer.

Jia Y, Cao B, Yang Y, Linghu E, Zhan Q, Lu Y Oncotarget. 2015; 6(32):33470-85.

PMID: 26396173 PMC: 4741779. DOI: 10.18632/oncotarget.5272.

References

Gonzalez-Zulueta M, Ruppert J, Tokino K, Tsai Y, Spruck 3rd C, MIYAO N . Microsatellite instability in bladder cancer. Cancer Res. 1993; 53(23):5620-3. View

Sheu J, Huang G, Chou H, Lee P, Wang J, Lee H . Multiple hepatocellular carcinomas at the early stage have different clonality. Gastroenterology. 1993; 105(5):1471-6. DOI: 10.1016/0016-5085(93)90153-4. View

Peltomaki P, Lothe R, Aaltonen L, Pylkkanen L, Nystrom-Lahti M, Seruca R . Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res. 1993; 53(24):5853-5. View

Fujimoto Y, Hampton L, Wirth P, Wang N, Xie J, Thorgeirsson S . Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 1994; 54(1):281-5. View

Hsu H, Peng S, Lai P, Sheu J, Chen D, Lin L . Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer. 1994; 73(1):42-7. DOI: 10.1002/1097-0142(19940101)73:1<42::aid-cncr2820730109>3.0.co;2-d. View

Kamb A, Gruis N, Liu Q, Harshman K, Tavtigian S, STOCKERT E . A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994; 264(5157):436-40. DOI: 10.1126/science.8153634. View

Merlo A, MABRY M, Gabrielson E, Vollmer R, Baylin S, Sidransky D . Frequent microsatellite instability in primary small cell lung cancer. Cancer Res. 1994; 54(8):2098-101. View

Yeh S, Chen P, Chen H, Lai M, Wang C, Chen D . Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 1994; 54(15):4188-92. View

Fujiwara Y, Ohata H, Emi M, Okui K, Koyama K, Tsuchiya E . A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chromosomes Cancer. 1994; 10(1):7-14. DOI: 10.1002/gcc.2870100103. View

10.

Loeb L . Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 1994; 54(19):5059-63. View

11.

Miki Y, Swensen J, Futreal P, Harshman K, Tavtigian S, Liu Q . A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182):66-71. DOI: 10.1126/science.7545954. View

12.

Fujiwara Y, Ohata H, Kuroki T, Koyama K, Tsuchiya E, Monden M . Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogene. 1995; 10(5):891-5. View

13.

DE SOUZA A, Hankins G, Washington M, Fine R, Orton T, Jirtle R . Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene. 1995; 10(9):1725-9. View

14.

Yumoto Y, Hanafusa T, Hada H, Morita T, Ooguchi S, Shinji N . Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol. 1995; 10(2):179-85. DOI: 10.1111/j.1440-1746.1995.tb01075.x. View

15.

Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y . Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer. 1995; 72(2):383-5. PMC: 2034007. DOI: 10.1038/bjc.1995.342. View

16.

Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T . Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes Cancer. 1995; 13(3):163-7. DOI: 10.1002/gcc.2870130305. View

17.

Linardopoulos S, Street A, Quelle D, Parry D, Peters G, Sherr C . Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res. 1995; 55(22):5168-72. View

18.

DE SOUZA A, Hankins G, Washington M, Orton T, Jirtle R . M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet. 1995; 11(4):447-9. DOI: 10.1038/ng1295-447. View

19.

Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J . Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995; 378(6559):789-92. DOI: 10.1038/378789a0. View

20.

Yeh S, Chen P, Lai M, Chen D . Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production. Gastroenterology. 1996; 110(1):184-92. DOI: 10.1053/gast.1996.v110.pm8536855. View